134
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Changes in frequency of cannabis use among people with HIV during the COVID-19 pandemic: a multi-methods study to explore the underlying reasons for change

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, & ORCID Icon show all
Pages 470-480 | Received 09 May 2022, Accepted 31 Jan 2023, Published online: 10 Mar 2023

References

  • Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. 2020 National Survey of Drug Use and Health (NSDUH) [Internet]. Rockville, MD: United States Department of Health & Human Services; 2021 [accessed 2022 Apr 18]. https://www.samhsa.gov/data/release/2020-national-survey-drug-use-and-health-nsduh-releases
  • Mimiaga MJ, Reisner SL, Grasso C, Crane HM, Safren SA, Kitahata MM, Schumacher JE, Mathews WC, Mayer KH. Substance use among HIV-infected patients engaged in primary care in the United States: findings from the centers for AIDS research network of integrated clinical systems cohort. Am J Public Health. 2013 Jun 13;103:1457–67. doi:10.2105/AJPH.2012.301162.
  • Okafor CN, Cook RL, Chen X, Surkan PJ, Becker JT, Shoptaw S, Martin E, Plankey MW. Prevalence and correlates of marijuana use among HIV-seropositive and seronegative men in the Multicenter AIDS Cohort Study (MACS), 1984–2013. Am J Drug Alcohol Abuse. 2017 Sep 3;43:556–66. doi:10.1080/00952990.2016.1245738.
  • Sinha S, McCaul ME, Hutton HE, Monroe AK, Alvanzo A, Lesko C, Lau B, Keruly J, Moore RD, Chander G. Marijuana use and HIV treatment outcomes among PWH receiving care at an urban HIV clinic. J Subst Abuse Treat. 2017 Nov 1;82:102–06. doi:10.1016/j.jsat.2017.09.009.
  • D’souza G, Matson PA, Grady CD, Nahvi S, Merenstein D, Weber KM, Greenblatt R, Burian P, Wilson TE. Medicinal and recreational Marijuana use among HIV-infected women in the Women’s Interagency Hiv Study (WIHS) cohort, 1994–2010. JAIDS. 2012 Dec 15;61:618–26. doi:10.1097/QAI.0b013e318273ab3a.
  • Corless IB, Lindgren T, Holzemer W, Robinson L, Moezzi S, Kirksey K, Coleman C, Tsai Y-F, Sanzero Eller L, Hamilton MJ, et al. Marijuana effectiveness as an HIV self-care strategy. Clin Nurs Res. 2009 May 1;18:172–93. doi:10.1177/1054773809334958.
  • Ware MA, Wang T, Shapiro S, Robinson A, Ducruet T, Huynh T, Gamsa A, Bennett GJ, Collet J-P. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ. 2010 Oct 5;182:E694–701. doi:10.1503/cmaj.091414.
  • Haug NA, Padula CB, Sottile JE, Vandrey R, Heinz AJ, Bonn-Miller MO. Cannabis use patterns and motives: a comparison of younger, middle-aged, and older medical cannabis dispensary patients. Addict Behav. 2017 Sep;72:14–20. doi:10.1016/j.addbeh.2017.03.006.
  • Costiniuk CT, Saneei Z, Salahuddin S, Cox J, Routy JP, Rueda S, et al. Cannabis consumption in people living with HIV: reasons for use, secondary effects, and opportunities for health education. Cannabis Cannabinoid Res. 2019 May 14;4:204–13. doi:10.1089/can.2018.0068.
  • Towe SL, Horton OE, Martin B, Meade CS. A comparison of motivations for Marijuana use in HIV-positive and HIV-negative adults. AIDS Behav. 2018 Sep 1;22:2807–14. doi:10.1007/s10461-018-2123-4.
  • Skalski LM, Towe SL, Sikkema KJ, Meade CS. The impact of marijuana use on memory in HIV-infected patients: a comprehensive review of the HIV and Marijuana literatures. Curr Drug Abuse Rev. 2017;9:126–41. doi:10.2174/1874473709666160502124503.
  • Okafor CN, Plankey MW, Li M, Chen X, Surkan PJ, Shoptaw S, Martin E, Cohen R, Sacktor N, Cook RL. Association of marijuana use with changes in cognitive processing speed and flexibility for 17 years in HIV-seropositive and HIV-seronegative men. Subst Use Misuse. 2019;54:525–37. doi:10.1080/10826084.2018.1495736.
  • Lorkiewicz SA, Ventura AS, Heeren TC, Winter MR, Walley AY, Sullivan M, Samet JH, Saitz R. Lifetime marijuana and alcohol use, and cognitive dysfunction in people with human immunodeficiency virus infection. Subst Abus. 2018 Jan 2;39:116–23. doi:10.1080/08897077.2017.1391925.
  • Roth MD, Baldwin GC, Tashkin DP. Effects of delta-9-tetrahydrocannabinol on human immune function and host defense. Chem Phys Lipids. 2002 Dec 31;121:229–39. doi:10.1016/S0009-3084(02)00159-7.
  • Cabral GA, Staab A. Effects on the immune system. Handb Exp Pharmacol. 2005;168:385–423.
  • Henriquez JE, Rizzo MD, Schultz MA, Crawford RB, Gulick P, Kaminski NE. Δ9-Tetrahydrocannabinold (THC) suppresses secretion of IFNα by plasmacytoid dendritic cells (pDC) from healthy and HIV-infected individuals. J Acquir Immune Defic Syndr. 2017 Aug 15;75:588–96. doi:10.1097/QAI.0000000000001449.
  • Fryman C, Lou B, Weber AG, Steinberg HN, Khanijo S, Iakovou A, et al. Acute respiratory failure associated with vaping. Chest. 2020 Mar;157:e63–8. doi:10.1016/j.chest.2019.10.057.
  • Ghasemiesfe M, Ravi D, Vali M, Korenstein D, Arjomandi M, Frank J, Austin PC, Keyhani S. Marijuana use, respiratory symptoms, and pulmonary function: a systematic review and meta-analysis. Ann Intern Med. 2018 Jul 17;169:106–15. doi:10.7326/M18-0522.
  • Hancox RJ, Sears MR. The impact of marijuana smoking on lung function. Europe Respiratory J [Internet]. 2019 Dec 1: 54:1902065. [accessed 2021 Mar 3]. https://erj.ersjournals.com/content/54/6/1902065
  • Lorenz DR, Uno H, Wolinsky SM, Gabuzda D. Effect of marijuana smoking on pulmonary disease in HIV-infected and uninfected men: a longitudinal cohort study. EClinicalMedicine. 2019 Jan 1;7:55–64. doi:10.1016/j.eclinm.2019.01.003.
  • Turcotte C, Blanchet MR, Laviolette M, Flamand N Impact of cannabis, cannabinoids, and endocannabinoids in the lungs. Front Pharmacol [Internet]. 2016;7. [accessed 2021 Mar 3]. https://www.frontiersin.org/articles/10.3389/fphar.2016.00317/full
  • Wenger DS, Crothers K. Marijuana smoking in men with HIV infection: a cause for concern. EClinicalMedicine. 2019 Jan 1;7:5–6. doi:10.1016/j.eclinm.2019.01.016.
  • Cook RL, Zhou Z, Kelso-Chichetto NE, Janelle J, Morano JP, Somboonwit C, et al., Alcohol consumption patterns and HIV viral suppression among persons receiving HIV care in Florida: an observational study. Addict Sci Clin Pract. 2017 27;12:22. doi:10.1186/s13722-017-0090-0.
  • Kahler CW, Liu T, Cioe PA, Bryant V, Pinkston MM, Kojic EM, Onen N, Baker JV, Hammer J, Brooks JT, et al. Direct and indirect effects of heavy alcohol use on clinical outcomes in a longitudinal study of HIV patients on ART. AIDS Behav. 2017 Jul 1;21:1825–35. doi:10.1007/s10461-016-1474-y.
  • Williams EC, McGinnis KA, Edelman EJ, Matson TE, Gordon AJ, Marshall BDL, Bryant KJ, Rubinsky AD, Lapham GT, Satre DD, et al. Level of alcohol use associated with hiv care continuum targets in a national U.S. Sample of persons living with HIV receiving healthcare. AIDS Behav. 2019 Jan 1;23:140–51. doi:10.1007/s10461-018-2210-6.
  • Montgomery L, Bagot K, Brown JL, Haeny AM. The association between marijuana use and HIV continuum of care outcomes: a systematic review. Curr HIV/AIDS Rep. 2019 Feb;16:17–28. doi:10.1007/s11904-019-00422-z.
  • Okafor CN, Zhou Z, Burrell LEB, Kelso NE, Whitehead NE, Harman JS, Cook CL, Cook RL. Marijuana use and viral suppression in persons receiving medical care for HIV-infection. Am J Drug Alcohol Abuse. 2017 Jan 2;43:103–10. doi:10.1080/00952990.2016.1191505.
  • Wang Y, Ibañez GE, Vaddiparti K, Stetten NE, Sajdeya R, Porges EC, Cohen RA, Cook RL. Change in marijuana use and its associated factors among persons living with HIV (PLWH) during the COVID-19 pandemic: findings from a prospective cohort. Drug Alcohol Depend. 2021 Aug 1;225:108770. doi:10.1016/j.drugalcdep.2021.108770.
  • Kroenke K, Strine TW, Spitzer RL, Williams JBW, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009 Apr 1;114:163–73. doi:10.1016/j.jad.2008.06.026.
  • SAS® 9.4. Cary, NC; 2013
  • Guest G, MacQueen KM, Namey EE. Applied thematic analysis. Thousand Oaks, CA, USA: SAGE Publications;2011 321p.
  • Braun V, Clarke V. Thematic analysis. In: Cooper H, Camic PM, Long L, Panter AT, Rindskopf D, Sher KJ, eds. APA handbook of research methods in psychology, vol 2: research designs: quantitative, qualitative, neuropsychological, and biological. Washington, DC, US: American Psychological Association; 2012. p. 57–71. ( APA handbooks in psychology®)
  • Hochstatter KR, Akhtar WZ, Dietz S, Pe-Romashko K, Gustafson DH, Shah DV, Krechel S, Liebert C, Miller R, El-Bassel N, et al. Potential influences of the COVID-19 pandemic on drug use and HIV care among people living with HIV and substance use disorders: experience from a pilot mhealth intervention. AIDS Behav. 2020 Jul 23:1–6. 10.1007/s10461-020-02976-1
  • Rolland B, Haesebaert F, Zante E, Benyamina A, Haesebaert J, Franck N. Global changes and factors of increase in caloric/salty food intake, screen use, and substance use during the early COVID-19 containment phase in the general population in France: survey study. JMIR Public Health Surveill. 2020 Sep 18;6:e19630. doi:10.2196/19630.
  • van Laar MW, Oomen PE, van Miltenburg CJA, Vercoulen E, Freeman TP, Hall WD Cannabis and COVID-19: reasons for concern. Front Psychiatry [Internet]. 2020 [accessed 2021 Jul 29]. https://www.frontiersin.org/articles/10.3389/fpsyt.2020.601653/full
  • Vidot DC, Islam JY, Camacho-Rivera Null M, Harrell MB, Rao DR, Chavez JV, Ochoa GL, Hlaing WM, Weiner M, Messiah SE. The COVID-19 cannabis health study: results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the United States. J Addict Dis. 2021 Mar;39:26–36. doi:10.1080/10550887.2020.1811455.
  • Meanley S, Choi SK, Thompson AB, Meyers JL, D’souza G, Adimora AA, Mimiaga MJ, Kempf M-C, Konkle-Parker D, Cohen MH, et al. Short-term binge drinking, marijuana, and recreational drug use trajectories in a prospective cohort of people living with HIV at the start of COVID-19 mitigation efforts in the United States. Drug Alcohol Depend. 2022 Feb 1.231:109233.10.1016/j.drugalcdep.2021.109233
  • Holingue C, Badillo-Goicoechea E, Riehm KE, Veldhuis CB, Thrul J, Johnson RM, et al. Mental distress during the COVID-19 pandemic among US adults without a pre-existing mental health condition: findings from American trend panel survey. Prev Med. 2020 Oct 1.139:106231.10.1016/j.ypmed.2020.106231
  • Taylor S, Landry CA, Paluszek MM, Fergus TA, McKay D, Asmundson GJG. COVID stress syndrome: concept, structure, and correlates. Depress Anxiety. 2020;37:706–14. doi:10.1002/da.23071.
  • Mannes ZL, Burrell LE, Ferguson EG, Zhou Z, Lu H, Somboonwit C, Cook R, Ennis N. The association of therapeutic versus recreational marijuana use and antiretroviral adherence among adults living with HIV in Florida. Patient Prefer Adher. 2018 Jul 27;12:1363–72. doi:10.2147/PPA.S167826.
  • Sajdeya R, Joseph V, Stetten N, Ibañez G, Wang Y, Powell L, Somboonwit C, Corsi K, Cook R. Reasons for marijuana use and its perceived effectiveness in therapeutic and recreational marijuana users among people living with HIV in Florida. Cannabis. 2021 Feb 18;4:40–52. doi:10.26828/cannabis/2021.01.002.
  • Knell G, Robertson MC, Dooley EE, Burford K, Mendez KS. Health behavior changes during COVID-19 pandemic and subsequent “stay-at-home” orders. Int J Environ Res Public Health. 2020 Jan;17:6268. doi:10.3390/ijerph17176268.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.